Literature DB >> 21397841

Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch.

Fangfei Li1, Yu Lan, Youliang Wang, Jun Wang, Guan Yang, Fanwei Meng, Hua Han, Anming Meng, Yaping Wang, Xiao Yang.   

Abstract

Cerebrovascular dysfunction is strongly associated with neonatal intracranial hemorrhage (ICH) and stroke in adults. Cerebrovascular endothelial cells (ECs) play important roles in maintaining a stable cerebral circulation in the central nervous system by interacting with pericytes. However, the genetic mechanisms controlling the functions of cerebral ECs are still largely unknown. Here, we report that disruption of Smad4, the central intracellular mediator of transforming growth factor-β (TGF-β) signaling, specifically in the cerebral ECs, results in perinatal ICH and blood-brain barrier breakdown. Furthermore, the mutant vessels exhibit defective mural cell coverage. Smad4 stabilizes cerebrovascular EC-pericyte interactions by regulating the transcription of N-cadherin through associating with the Notch intracellular complex at the RBP-J binding site of the N-cadherin promoter. These findings uncover a distinct role of endothelial Smad4 in maintaining cerebrovascular integrity and suggest important implications for genetic or functional deficiencies in TGF-β/Smad signaling in the pathogenesis of cerebrovascular dysfunction.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21397841     DOI: 10.1016/j.devcel.2011.01.011

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  108 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

2.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

Review 3.  Notch signaling in ocular vasculature development and diseases.

Authors:  Guo-Rui Dou; Lin Wang; Yu-Sheng Wang; Hua Han
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 4.  The blood-brain barrier.

Authors:  Felix Dyrna; Sophie Hanske; Martin Krueger; Ingo Bechmann
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-06       Impact factor: 4.147

Review 5.  Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Authors:  Jialing Liu; Yongting Wang; Yosuke Akamatsu; Chih Cheng Lee; R Anne Stetler; Michael T Lawton; Guo-Yuan Yang
Journal:  Prog Neurobiol       Date:  2013-11-27       Impact factor: 11.685

Review 6.  Notch Signaling in Vascular Smooth Muscle Cells.

Authors:  J T Baeten; B Lilly
Journal:  Adv Pharmacol       Date:  2016-08-26

7.  p38 MAP kinase mediates transforming-growth factor-β1-induced upregulation of matrix metalloproteinase-9 but not -2 in human brain pericytes.

Authors:  Yoko Takahashi; Takakuni Maki; Anna C Liang; Kanako Itoh; Josephine Lok; Noriko Osumi; Ken Arai
Journal:  Brain Res       Date:  2014-10-22       Impact factor: 3.252

8.  Deficiency of MFSD7c results in microcephaly-associated vasculopathy in Fowler syndrome.

Authors:  Pazhanichamy Kalailingam; Kai Qi Wang; Xiu Ru Toh; Toan Q Nguyen; Madhuvanthi Chandrakanthan; Zafrul Hasan; Clair Habib; Aharon Schif; Francesca Clementina Radio; Bruno Dallapiccola; Karin Weiss; Long N Nguyen
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

9.  ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.

Authors:  Bruno Larrivée; Claudia Prahst; Emma Gordon; Raquel del Toro; Thomas Mathivet; Antonio Duarte; Michael Simons; Anne Eichmann
Journal:  Dev Cell       Date:  2012-03-13       Impact factor: 12.270

10.  Transforming growth factor β-regulated microRNA-29a promotes angiogenesis through targeting the phosphatase and tensin homolog in endothelium.

Authors:  Jun Wang; Youliang Wang; Yu Wang; Ying Ma; Yu Lan; Xiao Yang
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.